Coronado Industries Announces the Appointment of Francesco Aspes, M.D. as Director of European Distribution.

Business Editors

FOUNTAIN HILLS, Ariz.--(BUSINESS WIRE)--June 9, 2003

Coronado Industries Inc. (OTC BB: CDIK), a manufacturer of proprietary pneumatic devices for the treatment of glaucoma, announces the appointment of Francesco Aspes, M.D. as its director of European distribution reporting directly to John W. Sharkey, Ph.D., director of operations. By assuming the European sales and distribution responsibility, Aspes fills a key position on Coronado's team. He will be responsible for expanding Coronado's European business, improving customer relationships and managing the distribution flow of the company's patented Pneumatic Trabeculoplasty (PNT(TM)).

Aspes comes directly from Novartis Ophthalmic, Buelach, Switzerland where he served as head of European operations. His responsibilities included market development, sales and distribution for all major accounts in 17 European countries overseeing 300 people. Aspes and his staff were responsible for a sales growth of 16 percent in 2002. Prior to Novartis, he was general manager of CIBA Vision Group, Venice, Italy, where he managed the optics and ophthalmic business unit of 150 people. Aspes is a member of the Italian Society Ophthalmology and earned a medical doctor degree in 1983 from the University of "La Sapienza" in Rome.

Sharkey said, "I have worked with Francesco for several years and his results absolutely speak for themselves. He has proven he can achieve positive results. He has the experience we need to take Coronado to the next level in Europe. We are indeed pleased to be able to attract a professional of Francesco's caliber and I am confident he will make a very POSITIVE and IMMEDIATE contribution to Coronado's sales and distribution efforts."

"It should be obvious to everyone that between John Sharkey, Ph.D. and Francesco Aspes, M.D., we now have the experience and ability to set up a comprehensive distribution network throughout Europe. I fully expect that this will be in our very near future. The addition of Dr. Aspes to our team is just the first step taken by our newly appointed Director of Operations John Sharkey, and is only one of many to come as he puts his business plan for Coronado into motion. Things are coming together quickly," said G. Richard Smith, CEO of Coronado Industries.

"I am very excited about joining Coronado's team and share their vision of building a highly successful, unique company. I am looking forward to expanding Coronado's business across Europe," said Aspes.

About Coronado Industries Inc.

Coronado Industries Inc., through its wholly owned subsidiary Ophthalmic International, focuses on the development and testing of a patented procedure, Pneumatic Trabeculoplasty (PNT). PNT, a two-minute non-invasive procedure, is currently being evaluated as a cost-effective alternative for the treatment of the most common types of glaucoma: open angle and pigmentary. During PNT, a suction device is applied to the eye for two minutes with the intention of reducing intraocular pressure.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.